APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ultrasonic Microbubble Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ultrasonic Microbubble Contrast Agents Market Outlook and Growth Opportunities 2026

27 December 2025205 pages

Choose your research edition.

Industry ResearchUltrasonic Microbubble Contrast Agents Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Ultrasonic Microbubble Contrast Agents Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Ultrasonic Microbubble Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ultrasonic Microbubble Contrast Agents Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Ultrasonic Microbubble Contrast Agents Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Ultrasonic Microbubble Contrast Agents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ultrasonic Microbubble Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ultrasonic Microbubble Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ultrasonic Microbubble Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ultrasonic Microbubble Contrast Agents market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ultrasonic Microbubble Contrast Agents market include Bayer, Bracco, GE Healthcare, ImaRx Therapeutics, Lantheus Medical Imaging, Microvascular Therapeutics, Miltenyi Biotec, NanoPET Pharma and POINTbiomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ultrasonic Microbubble Contrast Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ultrasonic Microbubble Contrast Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ultrasonic Microbubble Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ultrasonic Microbubble Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Ultrasonic Microbubble Contrast Agents Segment by Company

Bayer

Bracco

GE Healthcare

ImaRx Therapeutics

Lantheus Medical Imaging

Microvascular Therapeutics

Miltenyi Biotec

NanoPET Pharma

POINTbiomedical

Feiruida Medical

Fuman Group

Runkun Pharmaceutical

Lizhuo Pharmaceutical

Qi-hui Biopharmaceutical

SUNΛ Med-Engineering

Starleaf

Ultrasonic Microbubble Contrast Agents Segment by Type

Liposome Envelope

Multimer-based Envelope

Albumin-based Envelope

Others

Ultrasonic Microbubble Contrast Agents Segment by Application

Angiographic Ultrasonography

Cardiac Ultrasonography

Liver Ultrasonography

Others

Ultrasonic Microbubble Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ultrasonic Microbubble Contrast Agents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ultrasonic Microbubble Contrast Agents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ultrasonic Microbubble Contrast Agents significant trends, drivers, influence factors in global and regions.

6. To analyze Ultrasonic Microbubble Contrast Agents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ultrasonic Microbubble Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ultrasonic Microbubble Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ultrasonic Microbubble Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ultrasonic Microbubble Contrast Agents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ultrasonic Microbubble Contrast Agents industry.

Chapter 3: Detailed analysis of Ultrasonic Microbubble Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ultrasonic Microbubble Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ultrasonic Microbubble Contrast Agents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ultrasonic Microbubble Contrast Agents Industry Trends Table 2. Ultrasonic Microbubble Contrast Agents Industry Drivers Table 3. Ultrasonic Microbubble Contrast Agents Industry Opportunities and Challenges Table 4. Ultrasonic Microbubble Contrast Agents Industry Restraints Table 5. Global Ultrasonic Microbubble Contrast Agents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ultrasonic Microbubble Contrast Agents Revenue Share by Company (2021-2026) Table 7. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Company (Units) & (2021-2026) Table 8. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Company (2021-2026) Table 9. Global Ultrasonic Microbubble Contrast Agents Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ultrasonic Microbubble Contrast Agents Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ultrasonic Microbubble Contrast Agents Key Company Manufacturing Base & Headquarters Table 12. Global Ultrasonic Microbubble Contrast Agents Company, Product Type & Application Table 13. Global Ultrasonic Microbubble Contrast Agents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ultrasonic Microbubble Contrast Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Liposome Envelope Table 18. Significant Companies of Multimer-based Envelope Table 19. Significant Companies of Albumin-based Envelope Table 20. Significant Companies of Others Table 21. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 22. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Type (2021-2026) & (Units) Table 23. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Type (2027-2032) & (Units) Table 24. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Type (2021-2026) Table 25. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Type (2027-2032) Table 26. Global Ultrasonic Microbubble Contrast Agents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ultrasonic Microbubble Contrast Agents Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Ultrasonic Microbubble Contrast Agents Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Type (2021-2026) Table 30. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Angiographic Ultrasonography Table 32. Significant Companies of Cardiac Ultrasonography Table 33. Significant Companies of Liver Ultrasonography Table 34. Significant Companies of Others Table 35. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 36. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Application (2021-2026) & (Units) Table 37. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Application (2027-2032) & (Units) Table 38. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Application (2021-2026) Table 39. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Application (2027-2032) Table 40. Global Ultrasonic Microbubble Contrast Agents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Ultrasonic Microbubble Contrast Agents Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Ultrasonic Microbubble Contrast Agents Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Application (2021-2026) Table 44. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Application (2027-2032) Table 45. Global Ultrasonic Microbubble Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 46. Global Ultrasonic Microbubble Contrast Agents Sales by Region (2021-2026) & (Units) Table 47. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Region (2021-2026) Table 48. Global Ultrasonic Microbubble Contrast Agents Sales by Region (2027-2032) & (Units) Table 49. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Region (2027-2032) Table 50. Global Ultrasonic Microbubble Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Ultrasonic Microbubble Contrast Agents Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Region (2021-2026) Table 53. Global Ultrasonic Microbubble Contrast Agents Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Region (2027-2032) Table 55. Global Ultrasonic Microbubble Contrast Agents Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Ultrasonic Microbubble Contrast Agents Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Ultrasonic Microbubble Contrast Agents Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 58. Global Ultrasonic Microbubble Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026) & (Units) Table 60. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2021-2026) Table 61. Global Ultrasonic Microbubble Contrast Agents Sales by Country (2027-2032) & (Units) Table 62. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Country (2027-2032) Table 63. Global Ultrasonic Microbubble Contrast Agents Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Ultrasonic Microbubble Contrast Agents Sales Value Market Share by Country (2021-2026) Table 65. Global Ultrasonic Microbubble Contrast Agents Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Ultrasonic Microbubble Contrast Agents Sales Value Market Share by Country (2027-2032) Table 67. Bayer Company Information Table 68. Bayer Business Overview Table 69. Bayer Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Bayer Ultrasonic Microbubble Contrast Agents Product Portfolio Table 71. Bayer Recent Development Table 72. Bracco Company Information Table 73. Bracco Business Overview Table 74. Bracco Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bracco Ultrasonic Microbubble Contrast Agents Product Portfolio Table 76. Bracco Recent Development Table 77. GE Healthcare Company Information Table 78. GE Healthcare Business Overview Table 79. GE Healthcare Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolio Table 81. GE Healthcare Recent Development Table 82. ImaRx Therapeutics Company Information Table 83. ImaRx Therapeutics Business Overview Table 84. ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio Table 86. ImaRx Therapeutics Recent Development Table 87. Lantheus Medical Imaging Company Information Table 88. Lantheus Medical Imaging Business Overview Table 89. Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolio Table 91. Lantheus Medical Imaging Recent Development Table 92. Microvascular Therapeutics Company Information Table 93. Microvascular Therapeutics Business Overview Table 94. Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio Table 96. Microvascular Therapeutics Recent Development Table 97. Miltenyi Biotec Company Information Table 98. Miltenyi Biotec Business Overview Table 99. Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolio Table 101. Miltenyi Biotec Recent Development Table 102. NanoPET Pharma Company Information Table 103. NanoPET Pharma Business Overview Table 104. NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolio Table 106. NanoPET Pharma Recent Development Table 107. POINTbiomedical Company Information Table 108. POINTbiomedical Business Overview Table 109. POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 111. POINTbiomedical Recent Development Table 112. Feiruida Medical Company Information Table 113. Feiruida Medical Business Overview Table 114. Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 116. Feiruida Medical Recent Development Table 117. Fuman Group Company Information Table 118. Fuman Group Business Overview Table 119. Fuman Group Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolio Table 121. Fuman Group Recent Development Table 122. Runkun Pharmaceutical Company Information Table 123. Runkun Pharmaceutical Business Overview Table 124. Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 126. Runkun Pharmaceutical Recent Development Table 127. Lizhuo Pharmaceutical Company Information Table 128. Lizhuo Pharmaceutical Business Overview Table 129. Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 131. Lizhuo Pharmaceutical Recent Development Table 132. Qi-hui Biopharmaceutical Company Information Table 133. Qi-hui Biopharmaceutical Business Overview Table 134. Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio Table 136. Qi-hui Biopharmaceutical Recent Development Table 137. SUNΛ Med-Engineering Company Information Table 138. SUNΛ Med-Engineering Business Overview Table 139. SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolio Table 141. SUNΛ Med-Engineering Recent Development Table 142. Starleaf Company Information Table 143. Starleaf Business Overview Table 144. Starleaf Ultrasonic Microbubble Contrast Agents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolio Table 146. Starleaf Recent Development Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Ultrasonic Microbubble Contrast Agents Distributors List Table 150. Ultrasonic Microbubble Contrast Agents Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Ultrasonic Microbubble Contrast Agents Product Image Figure 2. Global Ultrasonic Microbubble Contrast Agents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ultrasonic Microbubble Contrast Agents Sales (2021-2032) & (Units) Figure 5. Global Ultrasonic Microbubble Contrast Agents Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ultrasonic Microbubble Contrast Agents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Liposome Envelope Image Figure 10. Multimer-based Envelope Image Figure 11. Albumin-based Envelope Image Figure 12. Others Image Figure 13. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 14. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Type (2021-2032) Figure 16. Global Ultrasonic Microbubble Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ultrasonic Microbubble Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Type (2021-2032) Figure 19. Angiographic Ultrasonography Image Figure 20. Cardiac Ultrasonography Image Figure 21. Liver Ultrasonography Image Figure 22. Others Image Figure 23. Global Ultrasonic Microbubble Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 24. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Application (2021-2032) Figure 26. Global Ultrasonic Microbubble Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ultrasonic Microbubble Contrast Agents Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Application (2021-2032) Figure 29. Global Ultrasonic Microbubble Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 30. Global Ultrasonic Microbubble Contrast Agents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Ultrasonic Microbubble Contrast Agents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 34. North America Ultrasonic Microbubble Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Ultrasonic Microbubble Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 40. South America Ultrasonic Microbubble Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Ultrasonic Microbubble Contrast Agents Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Ultrasonic Microbubble Contrast Agents Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Liposome Envelope
  • Multimer-based Envelope
  • Albumin-based Envelope
  • Others
Applications
  • Angiographic Ultrasonography
  • Cardiac Ultrasonography
  • Liver Ultrasonography
  • Others
Companies covered
  • Bayer
  • Bracco
  • GE Healthcare
  • ImaRx Therapeutics
  • Lantheus Medical Imaging
  • Microvascular Therapeutics
  • Miltenyi Biotec
  • NanoPET Pharma
  • POINTbiomedical
  • Feiruida Medical
  • Fuman Group
  • Runkun Pharmaceutical
  • Lizhuo Pharmaceutical
  • Qi-hui Biopharmaceutical
  • SUNΛ Med-Engineering
  • Starleaf

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032)
  4. 1.2.2 Global Ultrasonic Microbubble Contrast Agents Sales Volume (2021-2032)
  5. 1.2.3 Global Ultrasonic Microbubble Contrast Agents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ultrasonic Microbubble Contrast Agents Market Dynamics
  1. 2.1 Ultrasonic Microbubble Contrast Agents Industry Trends
  2. 2.2 Ultrasonic Microbubble Contrast Agents Industry Drivers
  3. 2.3 Ultrasonic Microbubble Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Ultrasonic Microbubble Contrast Agents Industry Restraints
3 Ultrasonic Microbubble Contrast Agents Market by Company
  1. 3.1 Global Ultrasonic Microbubble Contrast Agents Company Revenue Ranking in 2025
  2. 3.2 Global Ultrasonic Microbubble Contrast Agents Revenue by Company (2021-2026)
  3. 3.3 Global Ultrasonic Microbubble Contrast Agents Sales Volume by Company (2021-2026)
  4. 3.4 Global Ultrasonic Microbubble Contrast Agents Average Price by Company (2021-2026)
  5. 3.5 Global Ultrasonic Microbubble Contrast Agents Company Ranking (2024-2026)
  6. 3.6 Global Ultrasonic Microbubble Contrast Agents Company Manufacturing Base and Headquarters
  7. 3.7 Global Ultrasonic Microbubble Contrast Agents Company Product Type and Application
  8. 3.8 Global Ultrasonic Microbubble Contrast Agents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ultrasonic Microbubble Contrast Agents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ultrasonic Microbubble Contrast Agents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ultrasonic Microbubble Contrast Agents Market by Type
  1. 4.1 Ultrasonic Microbubble Contrast Agents Type Introduction
  2. 4.1.1 Liposome Envelope
  3. 4.1.2 Multimer-based Envelope
  4. 4.1.3 Albumin-based Envelope
  5. 4.1.4 Others
  6. 4.2 Global Ultrasonic Microbubble Contrast Agents Sales Volume by Type
  7. 4.2.1 Global Ultrasonic Microbubble Contrast Agents Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ultrasonic Microbubble Contrast Agents Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Ultrasonic Microbubble Contrast Agents Sales Value by Type
  11. 4.3.1 Global Ultrasonic Microbubble Contrast Agents Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Ultrasonic Microbubble Contrast Agents Sales Value by Type (2021-2032)
  13. 4.3.3 Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Type (2021-2032)
5 Ultrasonic Microbubble Contrast Agents Market by Application
  1. 5.1 Ultrasonic Microbubble Contrast Agents Application Introduction
  2. 5.1.1 Angiographic Ultrasonography
  3. 5.1.2 Cardiac Ultrasonography
  4. 5.1.3 Liver Ultrasonography
  5. 5.1.4 Others
  6. 5.2 Global Ultrasonic Microbubble Contrast Agents Sales Volume by Application
  7. 5.2.1 Global Ultrasonic Microbubble Contrast Agents Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ultrasonic Microbubble Contrast Agents Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Ultrasonic Microbubble Contrast Agents Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Ultrasonic Microbubble Contrast Agents Sales Value by Application
  11. 5.3.1 Global Ultrasonic Microbubble Contrast Agents Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ultrasonic Microbubble Contrast Agents Sales Value by Application (2021-2032)
  13. 5.3.3 Global Ultrasonic Microbubble Contrast Agents Sales Value Share by Application (2021-2032)
6 Ultrasonic Microbubble Contrast Agents Regional Sales and Value Analysis
  1. 6.1 Global Ultrasonic Microbubble Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ultrasonic Microbubble Contrast Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Ultrasonic Microbubble Contrast Agents Sales by Region: 2021-2026
  4. 6.2.2 Global Ultrasonic Microbubble Contrast Agents Sales by Region (2027-2032)
  5. 6.3 Global Ultrasonic Microbubble Contrast Agents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ultrasonic Microbubble Contrast Agents Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ultrasonic Microbubble Contrast Agents Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ultrasonic Microbubble Contrast Agents Sales Value by Region (2027-2032)
  9. 6.5 Global Ultrasonic Microbubble Contrast Agents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032)
  12. 6.6.2 North America Ultrasonic Microbubble Contrast Agents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032)
  15. 6.7.2 Europe Ultrasonic Microbubble Contrast Agents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ultrasonic Microbubble Contrast Agents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032)
  21. 6.9.2 South America Ultrasonic Microbubble Contrast Agents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ultrasonic Microbubble Contrast Agents Sales Value Share by Country, 2025 VS 2032
7 Ultrasonic Microbubble Contrast Agents Country-level Sales and Value Analysis
  1. 7.1 Global Ultrasonic Microbubble Contrast Agents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ultrasonic Microbubble Contrast Agents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2032)
  4. 7.3.1 Global Ultrasonic Microbubble Contrast Agents Sales by Country (2021-2026)
  5. 7.3.2 Global Ultrasonic Microbubble Contrast Agents Sales by Country (2027-2032)
  6. 7.4 Global Ultrasonic Microbubble Contrast Agents Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ultrasonic Microbubble Contrast Agents Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ultrasonic Microbubble Contrast Agents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ultrasonic Microbubble Contrast Agents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ultrasonic Microbubble Contrast Agents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ultrasonic Microbubble Contrast Agents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer
  2. 8.1.1 Bayer Company Information
  3. 8.1.2 Bayer Business Overview
  4. 8.1.3 Bayer Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bayer Ultrasonic Microbubble Contrast Agents Product Portfolio
  6. 8.1.5 Bayer Recent Developments
  7. 8.2 Bracco
  8. 8.2.1 Bracco Company Information
  9. 8.2.2 Bracco Business Overview
  10. 8.2.3 Bracco Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bracco Ultrasonic Microbubble Contrast Agents Product Portfolio
  12. 8.2.5 Bracco Recent Developments
  13. 8.3 GE Healthcare
  14. 8.3.1 GE Healthcare Company Information
  15. 8.3.2 GE Healthcare Business Overview
  16. 8.3.3 GE Healthcare Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GE Healthcare Ultrasonic Microbubble Contrast Agents Product Portfolio
  18. 8.3.5 GE Healthcare Recent Developments
  19. 8.4 ImaRx Therapeutics
  20. 8.4.1 ImaRx Therapeutics Company Information
  21. 8.4.2 ImaRx Therapeutics Business Overview
  22. 8.4.3 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 ImaRx Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio
  24. 8.4.5 ImaRx Therapeutics Recent Developments
  25. 8.5 Lantheus Medical Imaging
  26. 8.5.1 Lantheus Medical Imaging Company Information
  27. 8.5.2 Lantheus Medical Imaging Business Overview
  28. 8.5.3 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lantheus Medical Imaging Ultrasonic Microbubble Contrast Agents Product Portfolio
  30. 8.5.5 Lantheus Medical Imaging Recent Developments
  31. 8.6 Microvascular Therapeutics
  32. 8.6.1 Microvascular Therapeutics Company Information
  33. 8.6.2 Microvascular Therapeutics Business Overview
  34. 8.6.3 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Microvascular Therapeutics Ultrasonic Microbubble Contrast Agents Product Portfolio
  36. 8.6.5 Microvascular Therapeutics Recent Developments
  37. 8.7 Miltenyi Biotec
  38. 8.7.1 Miltenyi Biotec Company Information
  39. 8.7.2 Miltenyi Biotec Business Overview
  40. 8.7.3 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Miltenyi Biotec Ultrasonic Microbubble Contrast Agents Product Portfolio
  42. 8.7.5 Miltenyi Biotec Recent Developments
  43. 8.8 NanoPET Pharma
  44. 8.8.1 NanoPET Pharma Company Information
  45. 8.8.2 NanoPET Pharma Business Overview
  46. 8.8.3 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 NanoPET Pharma Ultrasonic Microbubble Contrast Agents Product Portfolio
  48. 8.8.5 NanoPET Pharma Recent Developments
  49. 8.9 POINTbiomedical
  50. 8.9.1 POINTbiomedical Company Information
  51. 8.9.2 POINTbiomedical Business Overview
  52. 8.9.3 POINTbiomedical Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 POINTbiomedical Ultrasonic Microbubble Contrast Agents Product Portfolio
  54. 8.9.5 POINTbiomedical Recent Developments
  55. 8.10 Feiruida Medical
  56. 8.10.1 Feiruida Medical Company Information
  57. 8.10.2 Feiruida Medical Business Overview
  58. 8.10.3 Feiruida Medical Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Feiruida Medical Ultrasonic Microbubble Contrast Agents Product Portfolio
  60. 8.10.5 Feiruida Medical Recent Developments
  61. 8.11 Fuman Group
  62. 8.11.1 Fuman Group Company Information
  63. 8.11.2 Fuman Group Business Overview
  64. 8.11.3 Fuman Group Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Fuman Group Ultrasonic Microbubble Contrast Agents Product Portfolio
  66. 8.11.5 Fuman Group Recent Developments
  67. 8.12 Runkun Pharmaceutical
  68. 8.12.1 Runkun Pharmaceutical Company Information
  69. 8.12.2 Runkun Pharmaceutical Business Overview
  70. 8.12.3 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Runkun Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  72. 8.12.5 Runkun Pharmaceutical Recent Developments
  73. 8.13 Lizhuo Pharmaceutical
  74. 8.13.1 Lizhuo Pharmaceutical Company Information
  75. 8.13.2 Lizhuo Pharmaceutical Business Overview
  76. 8.13.3 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Lizhuo Pharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  78. 8.13.5 Lizhuo Pharmaceutical Recent Developments
  79. 8.14 Qi-hui Biopharmaceutical
  80. 8.14.1 Qi-hui Biopharmaceutical Company Information
  81. 8.14.2 Qi-hui Biopharmaceutical Business Overview
  82. 8.14.3 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Qi-hui Biopharmaceutical Ultrasonic Microbubble Contrast Agents Product Portfolio
  84. 8.14.5 Qi-hui Biopharmaceutical Recent Developments
  85. 8.15 SUNΛ Med-Engineering
  86. 8.15.1 SUNΛ Med-Engineering Company Information
  87. 8.15.2 SUNΛ Med-Engineering Business Overview
  88. 8.15.3 SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 SUNΛ Med-Engineering Ultrasonic Microbubble Contrast Agents Product Portfolio
  90. 8.15.5 SUNΛ Med-Engineering Recent Developments
  91. 8.16 Starleaf
  92. 8.16.1 Starleaf Company Information
  93. 8.16.2 Starleaf Business Overview
  94. 8.16.3 Starleaf Ultrasonic Microbubble Contrast Agents Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Starleaf Ultrasonic Microbubble Contrast Agents Product Portfolio
  96. 8.16.5 Starleaf Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ultrasonic Microbubble Contrast Agents Value Chain Analysis
  2. 9.1.1 Ultrasonic Microbubble Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ultrasonic Microbubble Contrast Agents Sales Mode & Process
  6. 9.2 Ultrasonic Microbubble Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ultrasonic Microbubble Contrast Agents Distributors
  9. 9.2.3 Ultrasonic Microbubble Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst